These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

320 related items for PubMed ID: 29460791

  • 1. Hypercholesterolemia and hypertriglyceridemia as risk factors of liver dysfunction in children with inflammation receiving total parenteral nutrition.
    Golucci APBS, Morcillo AM, Hortencio TDR, Ribeiro AF, Nogueira RJN.
    Clin Nutr ESPEN; 2018 Feb; 23():148-155. PubMed ID: 29460791
    [Abstract] [Full Text] [Related]

  • 2. Hepatobiliary complications in healthy, intra-abdominally infected, and high-output fistula rats receiving total parenteral nutrition.
    Mok KT.
    JPEN J Parenter Enteral Nutr; 1993 Feb; 17(5):449-53. PubMed ID: 8289412
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Liver dysfunction associated with artificial nutrition in critically ill patients.
    Grau T, Bonet A, Rubio M, Mateo D, Farré M, Acosta JA, Blesa A, Montejo JC, de Lorenzo AG, Mesejo A, Working Group on Nutrition and Metabolism of the Spanish Society of Critical Care.
    Crit Care; 2007 Feb; 11(1):R10. PubMed ID: 17254321
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Ursodeoxycholic acid for treatment of cholestasis in children on long-term total parenteral nutrition: a pilot study.
    Spagnuolo MI, Iorio R, Vegnente A, Guarino A.
    Gastroenterology; 1996 Sep; 111(3):716-9. PubMed ID: 8780577
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Early use of cyclic TPN prevents further deterioration of liver functions for the TPN patients with impaired liver function.
    Hwang TL, Lue MC, Chen LL.
    Hepatogastroenterology; 2000 Sep; 47(35):1347-50. PubMed ID: 11100349
    [Abstract] [Full Text] [Related]

  • 14. Tauroursodeoxycholic acid (TUDCA) in the prevention of total parenteral nutrition-associated liver disease.
    Heubi JE, Wiechmann DA, Creutzinger V, Setchell KD, Squires R, Couser R, Rhodes P.
    J Pediatr; 2002 Aug; 141(2):237-42. PubMed ID: 12183720
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Glycyrrhizin represses total parenteral nutrition-associated acute liver injury in rats by suppressing endoplasmic reticulum stress.
    Tsai JJ, Kuo HC, Lee KF, Tsai TH.
    Int J Mol Sci; 2013 Jun 14; 14(6):12563-80. PubMed ID: 23771023
    [Abstract] [Full Text] [Related]

  • 18. Metabolic changes during prolonged total parenteral nutrition in intensive care.
    Castelli E, Cetrullo C, Zanello M.
    Resuscitation; 1978 Jun 14; 6(4):235-42. PubMed ID: 39324
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. High calorie infusion-induced hepatic impairments in infants.
    Hirai Y, Sanada Y, Fujiwara T, Hasegawa S, Kuwabara N.
    JPEN J Parenter Enteral Nutr; 1979 Jun 14; 3(3):146-50. PubMed ID: 113577
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 16.